Table 2 Lowest POD for PFAS based on liver effects - PFSAs
In this guide
In this guideThis is a paper for discussion. This does not represent the views of the Committee and should not be cited.
*Derived by contractor; NA – not applicable.
Substance / reference / table |
Sex, strain and species (Duration) |
NOAEL/LOAEL mg/kg bw/day |
Effect at LOAEL |
PFBS Chen et al. (2022) Table 17 |
Male C57BL/6 mice, 28 days.
|
Males: 2 / 104.
|
↑ apoptosis ↓ CAT activity Changes in hepatic lipidome. |
PFHxS Butenhoff et al. (2009) Table 18 Chang et al. (2018) Table 18 |
Male Crl:CD®(SD) IGS BR VAF/Plus® 42 days. Male Crl:CD1 mice 42 days. |
Males: NA / 0.3.
|
↓ serum cholesterol, ↑ centrilobular hypertrophy.
|
PFOS Butenhoff et al. (2012b) Table 19 |
Male and female Crl:CD®(SD) IGS BR rats, 104 weeks. |
Males/females: 0.024 / 0.098. |
Male ↑ hepatocellular centrilobular hypertrophy ↑ cystic hepatocellular Degeneration. Female ↑ hepatocellular periportal vacuolation ↓ serum total cholesterol. |